Significant Modifications of the Salivary Proteome Potentially Associated with Complications of Down Syndrome Revealed by Top-down Proteomics*

People with Down syndrome, a frequent genetic disorder in humans, have increased risk of health problems associated with this condition. One clinical feature of Down syndrome is the increased prevalence and severity of periodontal disease in comparison with the general population. Because saliva plays an important role in maintaining oral health, in the present study the salivary proteome of Down syndrome subjects was investigated to explore modifications with respect to healthy subjects. Whole saliva of 36 Down syndrome subjects, divided in the age groups 10–17 yr and 18–50 yr, was analyzed by a top-down proteomic approach, based on the high performance liquid chromatography-electrospray ionization–MS analysis of the intact proteins and peptides, and the qualitative and quantitative profiles were compared with sex- and age-matched control groups. The results showed the following interesting features: 1) as opposed to controls, in Down syndrome subjects the concentration of the major salivary proteins of gland origin did not increase with age; as a consequence concentration of acidic proline rich proteins and S cystatins were found significantly reduced in older Down syndrome subjects with respect to matched controls; 2) levels of the antimicrobial α-defensins 1 and 2 and histatins 3 and 5 were significantly increased in whole saliva of older Down syndrome subjects with respect to controls; 3) S100A7, S100A8, and S100A12 levels were significantly increased in whole saliva of Down syndrome subjects in comparison with controls. The increased level of S100A7 and S100A12 may be of particular interest as a biomarker of early onset Alzheimer's disease, which is frequently associated with Down syndrome.

[1]  S. Coburn,et al.  Nonprotein Nitrogenous Metabolites in Saliva in Down's Syndrome , 1967, Journal of dental research.

[2]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[3]  I. Nagaoka,et al.  Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation , 2008, Immunology.

[4]  M. Raftery,et al.  S100A8 and S100A9-oxidant scavengers in inflammation. , 2013, Free radical biology & medicine.

[5]  I. Chernushevich,et al.  Total chemical synthesis and chemotactic activity of human S100A12 (EN‐RAGE) , 2001, FEBS letters.

[6]  C. Fanali,et al.  The Surprising Composition of the Salivary Proteome of Preterm Human Newborn , 2010, Molecular & Cellular Proteomics.

[7]  T. Cabras,et al.  Different isoforms and post‐translational modifications of human salivary acidic proline‐rich proteins , 2005, Proteomics.

[8]  E. Peskind,et al.  S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10 , 2009, PloS one.

[9]  K. Macleod,et al.  Biomarkers of oxidative stress are significantly elevated in Down syndrome. , 1998, Free radical biology & medicine.

[10]  V. Prasher,et al.  Down's syndrome, dementia, and superoxide dismutase , 1993, British Journal of Psychiatry.

[11]  Zhongqi Zhang,et al.  A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra , 1998, Journal of the American Society for Mass Spectrometry.

[12]  J. Merrick,et al.  Salivary LL-37 Secretion in Individuals with Down Syndrome is Normal , 2006, Journal of dental research.

[13]  D. E. Deas,et al.  Systemic disease and periodontitis: manifestations of neutrophil dysfunction. , 2003, Periodontology 2000.

[14]  S. Gorr Antimicrobial peptides in periodontal innate defense. , 2012, Frontiers of oral biology.

[15]  O. Sanal,et al.  Neutrophil chemotaxis and periodontal status in Down's syndrome patients. , 1993, The Journal of Nihon University School of Dentistry.

[16]  I. Kola,et al.  An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis. , 2003, Journal of neural transmission. Supplementum.

[17]  Sven Cnattingius,et al.  Mortality and cancer incidence among individuals with Down syndrome. , 2003, Archives of internal medicine.

[18]  M. Sela,et al.  Caries levels, Streptococcus mutans counts, salivary pH, and periodontal treatment needs of adult Down syndrome patients. , 1991, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[19]  T. Cutress Composition, flow-rate and pH of mixed and parotid salivas from trisomic 21 and other mentally retarded subjects. , 1972, Archives of oral biology.

[20]  T. Cabras,et al.  Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. , 2005, European journal of oral sciences.

[21]  A. Becker,et al.  Stimulated parotid salivary flow rate in patients with Down syndrome. , 2002, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[22]  T. Cabras,et al.  A Cascade of 24 Histatins (Histatin 3 Fragments) in Human Saliva , 2004, Journal of Biological Chemistry.

[23]  F. Halgand,et al.  Defining intact protein primary structures from saliva: a step toward the human proteome project. , 2012, Analytical chemistry.

[24]  C. Soto,et al.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis , 2000, Nature Network Boston.

[25]  N. Roizen,et al.  Down's syndrome , 2003, The Lancet.

[26]  信行 佐々木 Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease , 2001 .

[27]  W. Siqueira,et al.  Salivary Proteome and Its Genetic Polymorphisms , 2007, Annals of the New York Academy of Sciences.

[28]  C. Fanali,et al.  HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). , 2009, Journal of separation science.

[29]  F. Halgand,et al.  Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry , 2010, Journal of the American Society for Mass Spectrometry.

[30]  Massimo Castagnola,et al.  Alterations of the Salivary Secretory Peptidome Profile in Children Affected by Type 1 Diabetes , 2010, Molecular & Cellular Proteomics.

[31]  D. Linseman,et al.  Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade. , 2012, Journal of Alzheimer's disease : JAD.

[32]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[33]  C. Fanali,et al.  Detection of Ca2+-binding S100 proteins in human saliva by HPLC-ESI-MS. , 2013, Methods in molecular biology.

[34]  P. Berti,et al.  Affinity purification and elimination of methionine oxidation in recombinant human cystatin C. , 1997, Protein expression and purification.

[35]  Y. Izumi,et al.  Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. , 1989, Journal of periodontology.

[36]  Scott A. Puckett,et al.  Longitudinal Study on Oral Health in Subjects with Alzheimer's Disease , 1994, Journal of the American Geriatrics Society.

[37]  P. Cichoń,et al.  Early-onset periodontitis associated with Down's syndrome--clinical interventional study. , 1998, Annals of periodontology.

[38]  C. Fanali,et al.  Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? , 2008, Journal of separation science.

[39]  D. Butterfield,et al.  Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia , 2011, Current gerontology and geriatrics research.

[40]  T. Cabras,et al.  Identification of the human salivary cystatin complex by the coupling of high‐performance liquid chromatography and ion‐trap mass spectrometry , 2003, Proteomics.

[41]  J. Palefsky,et al.  Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro , 2007, Journal of leukocyte biology.

[42]  C. Fanali,et al.  Detection in human saliva of different statherin and P‐B fragments and derivatives , 2006, Proteomics.

[43]  D. Friedman,et al.  The prevalence of periodontitis and dental caries in a Down's syndrome population. , 1986, Journal of periodontology.

[44]  C. Fanali,et al.  RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modified derivatives: S-Glutathionyl, S-cysteinyl and S-S 2-mer. , 2012, Journal of proteomics.

[45]  L. V. Van Eldik,et al.  S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. , 1994, Biochimica et biophysica acta.

[46]  F. Halgand,et al.  Micro-heterogeneity of human saliva peptide P-C characterized by high-resolution top-down fourier-transform mass spectrometry , 2010, Journal of the American Society for Mass Spectrometry.

[47]  C. Fanali,et al.  Age-dependent modifications of the human salivary secretory protein complex. , 2009, Journal of proteome research.

[48]  G. Perry,et al.  Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis , 2008, Journal of neurochemistry.